|1.||Cocco, Emiliano: 2 articles (07/2015 - 01/2015)|
|2.||Azodi, Masoud: 2 articles (07/2015 - 01/2015)|
|3.||Silasi, Dan-Arin: 2 articles (07/2015 - 01/2015)|
|4.||Bellone, Stefania: 2 articles (07/2015 - 01/2015)|
|5.||Ratner, Elena: 2 articles (07/2015 - 01/2015)|
|6.||Ferrari, Francesca: 2 articles (07/2015 - 01/2015)|
|7.||Lopez, Salvatore: 2 articles (07/2015 - 01/2015)|
|8.||Predolini, Federica: 2 articles (07/2015 - 01/2015)|
|9.||Santin, Alessandro D: 2 articles (07/2015 - 01/2015)|
|10.||Schwartz, Peter E: 2 articles (07/2015 - 01/2015)|
02/13/2015 - "Adoptive transfer experiments using CFSE-labeled MDSCs revealed that the TLR2-positive MDSCs survived long in tumor-bearing mice in response to Pam2CSK4 treatment. "
01/01/2015 - "The proliferative activity, activation, cytokine secretion (i.e., Type I vs Type II) and cytotoxicity of solitomab in autologous tumor-associated-T cells (TAL) in the pleural fluid of a CS patient were also evaluated by CFSE and flow-cytometry assays. "
07/01/2012 - "Further, we demonstrate the innovative application of CFSE to live sort slow-cycling tumor cells and validate their chemoresistance and tumorigenic potential."
01/01/2010 - "CFSE-stained cells were seen in tumors, also peaking at day 5 (2.1%). "
10/18/2008 - "It showed that the CFSE labeled cells mainly localized in the border of tumor, also a few in the tumor bed, and expressed albumin. "
|2.||Melanoma (Melanoma, Malignant)
07/01/2013 - "In the present study, in order to verify whether the persistence, distribution and function of effector cells can be improved by inhibiting immunosuppressive microenvironment, low-dose cyclophosphamide was previously intraperitoneally injected into melanoma-bearing C57BL/6 mice, thereafter, CFSE-labeled cytotoxic T lymphocytes were transfused intravenously, and their effective time, distributive pattern, and killing efficiency in different groups were observed by measuring the fluorescence intensity and cell cycle of cytotoxic T lymphocytes distributed in various organs, in comparison with tumor growth. "
09/01/2009 - "Cytotoxicity on multiple myeloma and melanoma cell lines was assessed by measuring dilution of the carboxyfluorescein diacetate succinimydylester dye (CFSE). "
02/29/2008 - "This method of TCRVbeta/CFSE dilution was used for the isolation of four different human lymphoma and melanoma-specific CD4(+) and CD8(+) T-cell clones reactive against defined and undefined tumor antigens. "
08/01/2013 - "Optimal staining concentration for CTL proliferation was determined by cell counting kit-8 (CCK-8) assay and killing efficiencies of CTLs or carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled melanoma antigen-specific cytotoxic T lymphocytes (CFSE-CTLs) for malignant melanoma cells in vitro were compared. "
12/01/2014 - "Furthermore, CFSE-based proliferation assay also showed that the proliferation of HBx-expressing podocytes was significantly inhibited than that of controls at 3-day post-infection, and that the difference became much more obvious at day 5 post-infection. "
05/01/2012 - "Staining of Bartonella henselae with carboxyfluorescein diacetate succinimidyl ester for tracking infection in erythrocytes and epithelial cells."
11/01/2011 - "Primary infections were performed with labeled larvae, while for challenge infections the reinfecting larvae were stained by CFSE. "
09/01/2011 - "The mechanism of inhibition of infection in TZM-bl cells is presumably as a result of the cytostatic or anti-proliferative activity that was observed for complex 4 in real time cell electronic sensing (RT-CES) and carboxyflourescein succinimidyl ester (CFSE) analysis. "
04/01/2011 - "Following infection of BALB/c mice by CFSE-labelled larvae it has been observed that staining had no influence on viability and further migratory activity of the parasites through the host organs (the intestine, liver, lungs and brain) where they were detected by SAIS until day 17 p.i. In addition, the dye did not affect larval antigenic activity as well as the development of related immune response. "
02/01/2007 - "In in vivo study, the melanoma B16 cells were labeled with CFSE and treated with CH50 and then they were injected into mice via mouse-tail veins. "
08/01/2013 - "Additionally, CFSE-CTLs were intravenously transfused to mice receiving B16 melanoma, and their residence time, migration, and distribution in vivo were observed by measuring fluorescence intensities of CFSE-CTLs per gram of tissue (%FI/g) in various tissues and analyzing tumor/non-tumor (T/NT) values. "
01/01/2015 - "As will be described in detail, our data confirmed that all three compounds exerted proapoptotic and antiproliferative activity in different B16 melanoma cell lines to a given extent, as revealed by an MTT assay, CFSE and DAPI staining. "
|5.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/01/2006 - "To study the effects of supernatant derived from acute myeloid leukemia (AML) cell lines on proliferation and apoptosis of CD4(+) and CD8(+) T cell subsets and to investigate the mechanism by which AML escapes from immune recognition, lymphocytes were labeled with CFSE and were stimulated with anti-CD3 and anti-CD28 in presence or absence of supernatants from three AML cell lines (HL-60, NB4, U937). "
|2.||5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)
|1.||Transplantation (Transplant Recipients)
|2.||Heterologous Transplantation (Xenotransplantation)
|4.||Homologous Transplantation (Allograft)